1. The role of the plasma sodium concentration in the regulation of aldosterone secretion and sodium excretion was investigated by comparing in 13 conscious sodium-depleted dogs the effects of the same sodium load (2-5 mmol/kg) given as either a hypertonic or hypotonic infusion.
Introduction
The importance of plasma sodium concentration (plasma "a+]) in the regulation of aldosterone showed that local increases in lNa+l in blood perfusing the adrenal gland caused decreases in aldosterone secretion in sodium-depleted sheep. It appears that local changes in "a+] can affect aldosterone secretion, but the contribution of such changes to the overall regulation of aldosterone secretion remains unanswered.
McCaa, Young, Guyton & McCaa [51 reported that a reduction in plasma "a+] by 20 mmol/l in intact and nephrectomized dogs produced large increases in plasma aldosterone concentration. Similarly, Cohen, Hulter, Smithline, Melby & Schwartz [6] found that chronic hyponatraemic volume expansion (maximum decrease in plasma "a+] = 31 mmol/l) was a potent stimulus to aldosterone secretion. In the above studies, since the changes in plasma "a+] were rather large, the physiological importance of such observations is questionable. The finding by Bie 171 that canrenoate, an aldosterone inhibitor, abolishes the decrease in sodium excretion brought about by a hypo-osmolar solution of glucose and urea (decrease in plasma "a+] = 4-6 mmol/l) in anaesthetized dogs, suggests that small changes in plasma "a+] may play a role in the regulation of aldosterone secretion.
The present study was undertaken to determine whether small sustained elevations in plasma "a+] would be effective in decreasing aldosterone secretion and, consequently, in increasing sodium excretion in conscious sodiumdepleted dogs.
Methods

Experimental design
Non-DOCA-treated sodium-depleted dogs. Thirteen dogs with a mean weight of 19.5 0.9 kg were placed in metabolic cages 7-8 days before an experiment and were fed 25 g of dry food (Purina dog chow)/kg body weight. The next morning they were given an intravenous injection of 110 mg of frusemide (donated by Hoechst-Roussel Pharmaceuticals Inc.) and were fed a can of low-sodium diet (2-3 mmol of sodium and 25-30 mmol of potassiumlcan; hld Prescription Diet, Riviana Foods, Topeka, KS, U.S.A.). A 24 h urine collection was obtained after injection of frusemide to determine the amount of sodium excreted in excess of intake. The dogs continued to receive a can of lowsodium diet and water ad libitum each day until the day of an experiment when food and water were withheld. Urine was collected every day for the next 2-4 days. On the day preceding an experiment a 24 h urine collection was obtained. On the morning of an experiment a 2 h control urine collection was obtained. Urine was collected by bladder catheterization. Complete urine collection was assured by air rinses; when urine volumes were less than 10 ml deionized water rinses were also used. A sodium load of 2.5 mmollkg (approximately 50 mmol of sodium) was given as a hypertonic [NaCl (1 mol/l), approx. 50 mll or hypotonic [NaCl (0.1 molll), approx. 500 mll infusion into a foreleg vein over a 10 min period. Urine collection periods were 0-2, 2-4, 4-7 and 7-22 h after the infusions. Blood samples were obtained immediately before and 25 min, 1,2,4, 7 and 22 h after beginning the infusions. Blood was collected by jugular venepuncture in seven dogs. Jugular venous catheters were inserted under local anaesthesia in the other six dogs to obtain additional blood for plasma aldosterone concentration and plasma renin activity measurements. Sodium, potassium and endogenous creatinine concentrations and urine volume were determined from urine samples; plasma sodium, potassium and endogenous creatinine concentrations and packed cell volumes were determined from blood samples. The dogs remained quietly in balance cages throughout the experiment and were disturbed only for bladder catheterization and blood sampling. Each dog received both infusions with 2-3 weeks between them. A random procedure was used to determine whether the hypertonic or hypotonic solution was given first.
DOCA-treated sodium-depleted dogs. If aldosterone secretion was an important component of the natriuretic response to either the hypertonic or hypotonic infusion, then maintenance of high mineralocorticoid levels should significantly alter the response of sodium-depleted dogs to these infusions. Therefore five dogs weighing 18.3 ? 1.5 kg were sodium depleted as described above. The experimental protocol was identical with that described above, except that the dogs received an injection of 10 mg of deoxycorticosterone acetate (DOCA) 2 h before and 7 h after the sodium load was given.
Analytical methods
Sodium and potassium concentrations of plasma and urine were measured with a flame photometer. Plasma and urinary creatinine concentrations were measured by the Jaffe reaction [81 with an auto-analyser. The. blood samples for plasma aldosterone and plasma renin activity were collected into a syringe containing 0.2 ml of 5% (w/v) disodium EDTA and were immediately placed on ice. Plasma aldosterone was measured by using a radioimmunoassay kit obtained from Diagnostic Products. The urinary C ,,-glucuronide conjugate of aldosterone was reconverted into aldosterone and extracted as described by Jowett, Slater, Piyasena & Ekins [91 with minor modifications. Urinary aldosterone concentration was then determined by radioimmunoassay with an antibody supplied by the Hormone Distribution Office of National Institutes of Health and [3H]aldosterone purchased from New England Nuclear. Plasma renin activity was measured by radioimmunoassay of the angiotensin I generated during incubation of plasma with angiotensinase and converting enzyme inhibitors (kit purchased from New England Nuclear). Appropriate analysis of variance and tests a posteriori [ 101 were used to analyse the measured variables. In the analysis of variance a comparison was considered significant if the probability of the F ratio was < 0-05. If multiple tests were performed a posteriori, the level of significance was adjusted so that the overall probability for all the observations was < 
Results
Effects of infusion of hypo-and hyper-tonic NaCl solutions in non-DOCA-treated sodium-depleted dogs
The average sodium loss in the 13 sodiumdepleted dogs after frusemide was 83.6 f 4.7 mmol and the average sodium excretion for days 2-6 after frusemide was 1.29 f 0.15 mmol/day. The effects of the hypo-and hyper-tonic infusions on plasma "a+], plasma [K+] and packed cell volume in sodium-depleted dogs are shown in Fig. l(a) The sustained elevation in plasma "a+] after the hypertonic infusion was associated with significant decreases in plasma aldosterone concentration (Fig. 2) . Although plasma aldosterone concentration also decreased after the hypotonic infusion, plasma aldosterone was significantly less at 7, 12 and 22 h after the hypertonic infusion as compared with the hypotonic infusion. No differences in plasma renin activity were observed either between infusions or with time during the 22 h experiment. Urinary aldosterone excretion was also significantly less after the hypertonic infusion (5.12 f 1.23 ng/h) as compared with the hypotonic infusion (8.42 f 1.03 ng/h) during the 22 h experiment.
The lower plasma aldosterone and urinary aldosterone excretion during the hypertonic 
FIG. 2. Effect of infusion of hypertonic (-0)
and hypotonic (0----0) NaCl solutions on plasma aldosterone concentration and plasma renin activity in non-DOCA-treated sodium-depleted dogs. *P < 0.05: if the asterisk is between the means, then the means for the two infusions are different at that time; if the asterisk is above or below a mean, then that mean is different from the control value for that variable.
infusion were associated with an enhanced natriuresis (Fig. 3a) . The 0-7 and 0-22 h cumulative sodium excretions were significantly greater after the hypertonic infusion as compared with the hypotonic infusion. This difference in cumulative sodium excretion was accompanied by differences in the rate of urinary sodium excretion and fractional sodium excretion (Table  2) . After the hypertonic infusion, the rate of urinary sodium excretion was greater during the 4-7 and 7-22 h periods and fractional sodium excretion was greater during the 2-4, 4-7 and 7-22 h periods when compared with the hypotonic infusion. By 22 h the sodium-depleted The effects of the hypertonic and hypotonic infusions on urine flow, filtered sodium load and urinary potassium excretion are presented in Table 2 . The increase in urine flow was significantly greater during the 0-2 and 0-4 h periods after hypotonic infusion as compared with the hypertonic infusion. No significant changes in creatinine clearance or filtered sodium load occurred during the course of the experiment. Urinary potassium excretion was significantly greater during all periods after hypertonic infusion as compared with hypotonic infusion.
Effects of infusions of hypo-and hyper-tonic NaCl solutions in DOCA-treated sodiumdepleted dogs
Five sodium-depleted dogs were given injections of DOCA (10 mg) twice during an experiment to maintain high mineralocorticoid levels. These dogs were sodium-depleted as previously described. The average sodium loss (87.7 f 12.3 mmol) and the average sodium excretion for days 2-6 after frusemide (2.14 f 0.53 mmol/day) in these dogs were not significantly different from that obtained in the non-DOCA-treated dogs.
The effects of the hypo-and hyper-tonic infusions on plasma "a+], plasma [K+l and packed cell volume in DOCA-treated sodiumdepleted dogs are presented in Fig. l(b) and * P < 0.05: if the asterisk is between the means, then the means between the two infusions are different for that period; if the asteisk is below a mean for an infusion, then that mean is different from that -2-0 value for that variable. Unlike non-DOCA-treated sodium-depleted dogs, elevation of plasma "a+] in DOCAtreated sodium-depleted dogs was not associated with an enhanced natriuresis (Fig. 3b) . The 0-22 h cumulative sodium excretion was not greater after the hypertonic infusion as compared with the hypotonic infusion. Similarly, the rate of urinary sodium excretion and fractional sodium excretion were not different at any time between the two infusions ( Table 3) . By 22 h, DOCAtreated sodium-depleted dogs excreted only 7.4 k 2.3% of the sodium load when it was given as a hypertonic infusion and 4.2 & 1.0% when given as a hypotonic infusion. A comparison of the differences (hypertonic infusion -hypotonic infusion) in cumulative sodium excretion between DOCA-treated and non-DOCA-treated sodiumdepleted dogs is shown in Fig. 4 . Not only was the absolute amount of sodium excreted significantly less in DOCA-treated than in non-DOCA-treated dogs, but the proportionate change was also different. The ratio (hypertonic/ hypotonic) of 0-22 h cumulative sodium excretion was 5-65 & 1.14 in non-DOCA-treated dogs and 1 a66 & 0.18 in DOCA-treated dogs.
The effects of the hyper-and hypo-tonic infusions on urine flow, creatinine clearance, filtered sodium load and urinary potassium excretion in DOCA-treated sodium-depleted dogs were not different from the effects of these two infusions on the same variables in non-DOCAtreated dogs (Table 3) . Therefore, the major difference between the responses of DOCAtreated and non-DOCA-treated sodium-depleted
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Time (h) Fig. 4 . Comparison of differences in cumulative sodium excretion between hypertonic and hypotonic NaCl infusions in non-DOCA-treated (0, n = 13) and DOCA-treated (U, n = 5) sodium-depleted dogs.
*P < 0.05. dogs to the hyper-and hypo-tonic infusions was related to alterations in rate of urinary sodium excretion, fractional sodium excretion and cumulative sodium excretion. All other measured variables were similar between the two groups of dogs.
Discussion
The results of the present study support the hypothesis that plasma "a+] plays a role in the regulation of aldosterone secretion. However, alternative interpretations of the data are possible. Instead of changes in plasma "a+] affecting aldosterone secretion, the two infusions might have produced different degrees of extracellular and plasma volume expansion, thus accounting for the difference in aldosterone secretion. This interpretation seems unlikely for three reasons. First, there were no differences in packed cell volume between the two infusions at any time. Secondly, as described by Schrier, Fein, McNeal & Cirksena [ 1 11, the hypotonic infusion would be expected to produce a greater extracellular and plasma volume expansion and hence a greater decrease in aldosterone secretion. Finally, a difference in volume expansion would be expected to cause differences in plasma renin activity and no such differences were evident. Another possibility is that the gradual decrease in plasma [K+l throughout the experiment could have contributed to the differences in aldosterone secretion. However, the differences in plasma [K+] between the two infusions were sporadic and probably not related to the differences in aldosterone secretion. Therefore, the most likely cause of the decrease in aldosterone secretion is an increase in plasma "a+].
The finding that decreases in plasma aldosterone concatration and urinary aldosterone excretion were associated with increases in urinary sodium excretion lends credence to the importance of aldosterone in the regulation of urinary sodium excretion in conscious sodium-depleted dogs. As the sensitivity of the renal sodium retention mechanism to aldosterone might be altered by chronic sodium depletion or by acute volume expansion in sodium-depleted dogs, it could be that the decreases in plasma aldosterone concentration played a rolejn the increased urinary sodium excretion observed after both infusions. That such might be the case is suggested by the finding that DOCA-treated sodium-depleted dogs did not excrete significantly more sodium after the infusions than they did for the 26 h before the infusions. The absence of a natriuretic response to these infusions in DOCA-treated sodiumdepleted dogs might seem surprising at first, but appears more logical when one realizes that the sodium load that they received was not sufficient to replace their documented sodium loss. Therefore, absence of a natriuretic response or a slight natriuretic response, such as after the hypotonic infusion in non-DOCA-treated dogs, might be more appropriate than the large increase in sodium excretion that occurred after the hypertonic infusion in non-DOCA-treated dogs. Such an inappropriate response in the face of sodium depletion might reflect the importance of plasma "a+] in the regulation of aldosterone secretion and hence in sodium excretion.
Not only did DOCA treatment suppress the natriuresis that occurred after hypertonic and hypotonic infusions, it also suppressed the difference in sodium excretion between the two infusions. Although such findings suggest that the differences in urinary sodium excretion were primarily dependent on the differences in aldosterone levels, it is possible that the large amounts of DOCA given prevented other factors which influenced sodium reabsorption from affecting sodium excretion. However, it should be noted that these dogs had very high endogenous aldosterone levels for 6-7 days before injection of DOCA. Furthermore, excess mineralocorticoid treatment has not been shown to affect the renin-aldosterone system andlor electrolyte balance in animals on low-sodium diets or in sodium-depleted animals [12] [13] [14] .
It is also possible that DOCA masked the differences in sodium excretion between the two infusions; i.e., the differences occurred in a proximal portion of the nephron and DOCA caused such avid sodium reabsorption in the distal nephron that the difference was obscured. If this was the case, the. ratio (hypertonic1 hypotonic) for the 0-22 h cumulative sodium excretion in the non-DOCA-and DOCA-treated dogs might not be different. However, the ratio in non-DOCA-treated dogs (5.65 & 1.14) was significantly greater than the ratio in DOCAtreated dogs (1.66 k 0.18). Therefore, while alterations in proximal sodium reabsorption could have contributed to the difference in sodium excretion between the two infusions, it does not appear to be a major component. In addition, Lassiter, Mylle & Gottschalk [I51 showed that infusion of hypertonic NaCl solution in rats did not alter fractional reabsorption of sodium by the proximal tubule and suggested that the natriuresis was primarily the result of a decrease in the fractional reabsorption of sodium in more distal parts of the nephron. Since DOCA virtually prevented the natriuresis that occurred after both infusions, it is likely that a difference in aldosterone secretion between the hyper-and hypo-tonic infusions was a major component in the difference in urinary sodium excretion. The fact that DOCA did not block the acute difference in urinary sodium excretion between hyper-and iso-tonic infusions in the study by Diaz-Buxo, Haas, Ott, Cuche, Marchand & Knox [I61 does not diminish the importance of changes in aldosterone in the present experiments. It is very likely that Diaz-Buxo et al. [I61 were observing the effects of an acute increase in filtered sodium load (increase in plasma "a+] = 15-20 mmol/l), whereas in the present study we are observing the effects of a small, long-term elevation in plasma "a+].
The mechanism by which elevations in plasma "a+] affect aldosterone secretion has not been clarified by the present study. Nash, Rostorfer, Bailie, Wathen & Schneider [I71 suggested that elevation of renal arterial sodium concentration inhibited renin release. However, we were unable to show any change in plasma renin activity after either hyper-or hypo-tonic infusions in conscious sodium-depleted dogs. Blair-West et al. [31 reported that an increase of adrenal blood sodium concentration produced by infusion of NaCl solution inhibited aldosterone secretion by 25%, although the suppression disappeared after 3-6 h despite continued infusion. In another study Blair-West et al. [ [51 also suggested that changes in plasma "a+] which caused changes in aldosterone secretion were mediated by an unidentified pituitary factor. Therefore, the mechanism by which plasma "a+] affects aldosterone secretion remains to be determined.
In summary, infusion of a sodium load which elevated plasma "a+] (hypertonic infusion) caused a greater decrease in plasma aldosterone concentration and urinary aldosterone excretion in conscious sodium-depleted dogs than did infusion of the same sodium load without an increase in plasma "a+] (hypotonic infusion).
The decrease in aldosterone secretion was associated with an enhanced natriuresis. Further, the enhanced natriuresis was prevented by injection of DOCA in sodium-depleted dogs. These data support the hypothesis that elevations in plasma "a+] are effective in decreasing aldosterone secretion and, hence, in increasing sodium excretion in conscious sodium-depleted dogs.
